Human T cell receptor-mediated recognition of HLA-E
- PMID: 11920559
- DOI: 10.1002/1521-4141(200204)32:4<936::AID-IMMU936>3.0.CO;2-M
Human T cell receptor-mediated recognition of HLA-E
Abstract
The HLA-E class Ib molecule presents hydrophobic peptides derived from the leader sequences of other class I molecules, constituting the ligands for CD94/NKG2 lectin-like receptors. Along the course of our studies on human CD94+ T cells, we characterized an alpha beta CD8+CD94/NKG2C+ CTL clone (K14). In cytolytic assays against the murine TAP-deficient RMA-S cells transfected with human beta2 microglobulin and HLA-E (RMA-S/HLA-E), loaded with different synthetic peptides, K14 displayed a pattern of specific recognition distinct to that observed in CD94/NKG2C+ NK clones tested in parallel. RMA-S/HLA-E cells loaded with some but not all HLA class I leader sequence peptides were efficiently recognized by K14 but not by CD94/NKG2C clones, andvice versa. Remarkably, K14 also reacted with HLA-E loaded with a peptide derived from the BZLF-1 Epstein-Barr virus protein. Anti-CD94 mAb did not prevent K14 cytotoxicity against RMA-S/HLA-E cells, whereas incubation with anti-clonotypic mAb specific for the K14 TCR markedly inhibited lysis. Soluble HLA-E tetramers refolded with different peptides (i.e. VMAPRTVLL, VMAPRTLIL, VMAPRTLFL) specifically stained K14 cells. HLA-E tetramer binding was minimally reduced by pretreatment with anti-CD94 mAb alone, but was completely prevented in combination with anti-clonotypic mAb. Altogether, the data unequivocally imply the generation of human T cells potentially recognizing through the alpha beta TCR HLA-E molecules that bind to class I- and virus-derived peptides.
Similar articles
-
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.Nature. 1998 Feb 19;391(6669):795-9. doi: 10.1038/35869. Nature. 1998. PMID: 9486650
-
HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes.Hum Immunol. 2004 May;65(5):437-45. doi: 10.1016/j.humimm.2004.02.001. Hum Immunol. 2004. PMID: 15172443
-
HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer.Eur J Immunol. 1998 Sep;28(9):2854-63. doi: 10.1002/(SICI)1521-4141(199809)28:09<2854::AID-IMMU2854>3.0.CO;2-W. Eur J Immunol. 1998. PMID: 9754572
-
Natural killer cell recognition of HLA class I molecules.Rev Immunogenet. 2000;2(3):433-48. Rev Immunogenet. 2000. PMID: 11256749 Review.
-
Natural killer cell surveillance of intracellular antigen processing pathways mediated by recognition of HLA-E and Qa-1b by CD94/NKG2 receptors.Microbes Infect. 2000 Apr;2(4):371-80. doi: 10.1016/s1286-4579(00)00330-0. Microbes Infect. 2000. PMID: 10817639 Review.
Cited by
-
Identification of HLA-E-specific alloreactive T lymphocytes: a cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells.Proc Natl Acad Sci U S A. 2002 Aug 20;99(17):11328-33. doi: 10.1073/pnas.172369799. Epub 2002 Aug 7. Proc Natl Acad Sci U S A. 2002. PMID: 12167676 Free PMC article.
-
Mycobacterium tuberculosis peptides presented by HLA-E molecules are _targets for human CD8 T-cells with cytotoxic as well as regulatory activity.PLoS Pathog. 2010 Feb 26;6(2):e1000782. doi: 10.1371/journal.ppat.1000782. PLoS Pathog. 2010. PMID: 20195504 Free PMC article.
-
A novel and efficient approach to high-throughput production of HLA-E/peptide monomer for T-cell epitope screening.Sci Rep. 2021 Aug 26;11(1):17234. doi: 10.1038/s41598-021-96560-9. Sci Rep. 2021. PMID: 34446788 Free PMC article.
-
Innovative Strategies to Identify M. tuberculosis Antigens and Epitopes Using Genome-Wide Analyses.Front Immunol. 2014 Jun 25;5:256. doi: 10.3389/fimmu.2014.00256. eCollection 2014. Front Immunol. 2014. PMID: 25009541 Free PMC article. Review.
-
Polymorphisms within the human leucocyte antigen-E gene and their associations with susceptibility to rheumatoid arthritis as well as clinical outcome of anti-tumour necrosis factor therapy.Clin Exp Immunol. 2015 Dec;182(3):270-7. doi: 10.1111/cei.12696. Epub 2015 Sep 28. Clin Exp Immunol. 2015. PMID: 26307125 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous